TY - JOUR
T1 - MELD scores do not predict patient morbidity while on the liver transplant waiting list
AU - Cowling, T.
AU - Jennings, L. W.
AU - Goldstein, R. M.
AU - Sanchez, E. Q.
AU - Chinnakotla, S.
AU - Dawson, S.
AU - Randall, H. B.
AU - Klintmalm, G. B.
AU - Levy, M. F.
PY - 2005/6
Y1 - 2005/6
N2 - The goals of this study were to assess waitlist morbidity in terms of the frequency of health care services utilized by patients while on the liver transplant (LTX) waiting list and to determine whether that utilization can be predicted by the Model for End-Stage Liver Disease (MELD). Sixty-three noncomatose subjects were followed from waitlist placement until death, change in status, LTX, or study discontinuance. Health care events included doctor/clinic visits, labs, outpatient/inpatient tests and procedures, and hospital/intensive care unit days. Listing MELD scores and LTX MELD scores were examined against the number of health care event occurrences within 60 days of listing and 60 days of LTX, respectively, as were changes in MELD scores between listing and LTX and differences in the number of occurrences between the two time points. The only significant correlations noted were between LTX MELD scores and number of hospital days near LTX (r = .360, P = .046) and between LTX MELD scores and the sum total number of occurrences near LTX (r = .370, P = .044). These results suggest that MELD scores do not appear to predict morbidity in terms of health care utilization in patients awaiting LTX. Developing a system capable of predicting waitlist morbidity may lead to the implementation of medical interventions aimed at circumventing foreseeable complications and/or crises in patients awaiting LTX.
AB - The goals of this study were to assess waitlist morbidity in terms of the frequency of health care services utilized by patients while on the liver transplant (LTX) waiting list and to determine whether that utilization can be predicted by the Model for End-Stage Liver Disease (MELD). Sixty-three noncomatose subjects were followed from waitlist placement until death, change in status, LTX, or study discontinuance. Health care events included doctor/clinic visits, labs, outpatient/inpatient tests and procedures, and hospital/intensive care unit days. Listing MELD scores and LTX MELD scores were examined against the number of health care event occurrences within 60 days of listing and 60 days of LTX, respectively, as were changes in MELD scores between listing and LTX and differences in the number of occurrences between the two time points. The only significant correlations noted were between LTX MELD scores and number of hospital days near LTX (r = .360, P = .046) and between LTX MELD scores and the sum total number of occurrences near LTX (r = .370, P = .044). These results suggest that MELD scores do not appear to predict morbidity in terms of health care utilization in patients awaiting LTX. Developing a system capable of predicting waitlist morbidity may lead to the implementation of medical interventions aimed at circumventing foreseeable complications and/or crises in patients awaiting LTX.
UR - http://www.scopus.com/inward/record.url?scp=21844436534&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=21844436534&partnerID=8YFLogxK
U2 - 10.1016/j.transproceed.2005.03.058
DO - 10.1016/j.transproceed.2005.03.058
M3 - Article
C2 - 15964371
AN - SCOPUS:21844436534
SN - 0041-1345
VL - 37
SP - 2174
EP - 2178
JO - Transplantation proceedings
JF - Transplantation proceedings
IS - 5
ER -